Liu Yuyuan, Liu Hong, Tu Xiwen, Peng Youming, Liu Fuyou, Zhang Fan, Guo Chunyan, Liu Yang, Yang Xinming, Chen Guochun, Liu Yinghong, Yuan Fang
Nephrology Department, Renal Research Institute, Hunan Key Laboratory of Kidney Disease and Blood Purification, Second Xiangya Hospital, Central South University, 139 Renmin Road, Changsha, 410011, Hunan, China.
Int Urol Nephrol. 2014 Jun;46(6):1153-9. doi: 10.1007/s11255-013-0606-9. Epub 2013 Nov 23.
We observed serum parameters and urinary findings of IgA nephropathy (IgAN) patients in the short and longer time after tonsillectomy, to provide evidences to clarify the role of tonsils in the pathogenesis of IgAN and the feasibility of tonsillectomy for IgAN patients.
For the short-term study, 19 patients with both IgAN and chronic tonsillitis (group A) and 19 patients with chronic tonsillitis (group B) were performed bilateral tonsillectomy and 19 healthy people as normal controls (group C). Another 115 patients with IgAN and chronic tonsillitis including 61 patients for tonsillectomy combined with drug therapy and 54 for drug therapy alone followed up for 12 months.
Fourteen patients of group A showed a deterioration of urinary findings, while only 2 patients of group B showed deterioration (P < 0.01). Both serum IgA and IgA1 levels were significantly higher in group A than that in group B or group C (P < 0.05, respectively). Levels of serum IgA and IgA1 of group A increased after tonsillectomy and did not increase instantly, but increased at day 3, then decreased at day 5. Both serum IgA and IgA1 levels were positively related to urinary red blood cell count (P < 0.01, r s = 0.362, r s = 0.347, respectively). For longer-term study, urinary findings of IgAN patients underwent tonsillectomy were improved significantly than that of patients without tonsillectomy (P < 0.05).
Tonsils play an important role in the development of IgAN, and tonsillectomy may be a feasible treatment method for IgAN patients with chronic tonsillitis.
观察扁桃体切除术后短期内及较长时间内IgA肾病(IgAN)患者的血清参数和尿液检查结果,为阐明扁桃体在IgAN发病机制中的作用以及扁桃体切除术对IgAN患者的可行性提供依据。
短期研究中,对19例IgAN合并慢性扁桃体炎患者(A组)和19例慢性扁桃体炎患者(B组)行双侧扁桃体切除术,19例健康人作为正常对照(C组)。另外115例IgAN合并慢性扁桃体炎患者,其中61例行扁桃体切除联合药物治疗,54例仅行药物治疗,随访12个月。
A组14例患者尿液检查结果恶化,而B组仅2例患者出现恶化(P<0.01)。A组血清IgA和IgA1水平均显著高于B组或C组(分别为P<0.05)。A组扁桃体切除术后血清IgA和IgA1水平升高,并非即刻升高,而是在术后第3天升高,第5天下降。血清IgA和IgA1水平均与尿红细胞计数呈正相关(分别为P<0.01,rs=0.362,rs=0.347)。长期研究中,行扁桃体切除术的IgAN患者尿液检查结果较未行扁桃体切除术的患者明显改善(P<0.05)。
扁桃体在IgAN的发病过程中起重要作用,扁桃体切除术可能是治疗合并慢性扁桃体炎的IgAN患者的一种可行治疗方法。